Association between baseline radiological tumor burden and outcomes in patients with metastatic breast cancer treated with an immune checkpoint inhibitor

被引：0
|
作者：
Brown, Lauren Claire
Moodie, Kate
VanGeelen, Courtney
Dixon-Douglas, Julia
David, Steven Philip
Francis, Prudence A.
Savas, Peter
Loi, Sherene
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Australia
[2] Peter MacCallum Canc Ctr, Caulfield, Australia
[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1103
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer
    Popat, Vinita
    Lu, Rong
    Ahmed, Murtaza
    Park, Jason Y.
    Xie, Yang
    Gerber, David E.
    [J]. ONCOLOGIST, 2020, 25 (06): : 515 - 522
  • [22] Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
    Williams, Tanya J.
    Benavides, David R.
    Patrice, Kelly-Ann
    Dalmau, Josep O.
    de Avila, Alexandre Leon Ribeiro
    Le, Dung T.
    Lipson, Evan J.
    Probasco, John C.
    Mowry, Ellen M.
    [J]. JAMA NEUROLOGY, 2016, 73 (08) : 928 - 933
  • [23] Burden of copy number alterations predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients
    Lu, Zhihao
    Chen, Huan
    Li, Shuang
    Jiao, Xi
    Wu, Lihong
    Zhang, Henghui
    Shen, Lin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors
    Zhang, Lilong
    Jin, Qi
    Chai, Dongqi
    Kuang, Tianrui
    Li, Chunlei
    Guan, Yongjun
    Liu, Li
    Wang, Weixing
    Deng, Wenhong
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation
    Pan, Catherina X.
    Lau, William C.
    Kim, Daniel Y.
    Lau, Charles B.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1264 - 1268
  • [26] Baseline Tumor Immune Cell Infiltration and Activation can Predict Checkpoint Inhibitor Pneumonitis in Lung Cancer Patients
    Bracht, J.
    Viteri, S.
    Aguilar, A.
    Garcia, J. J.
    Huang, C.
    Potie, N.
    Aldeguer, E.
    Gimenez-Capitan, A.
    Rodriguez, S.
    Roman, R.
    Warren, S.
    Rosell, R.
    Molina-Vila, M. A.
    Gonzalez-Cao, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S546 - S546
  • [27] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Iris Y. Sheng
    Shilpa Gupta
    Chandana A. Reddy
    Dana Angelini
    Pauline Funchain
    Tamara A. Sussman
    Joseph Sleiman
    Moshe C. Ornstein
    Keith McCrae
    Alok A. Khorana
    [J]. Targeted Oncology, 2022, 17 : 563 - 569
  • [28] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Sheng, Iris Y.
    Gupta, Shilpa
    Reddy, Chandana A.
    Angelini, Dana
    Funchain, Pauline
    Sussman, Tamara A.
    Sleiman, Joseph
    Ornstein, Moshe C.
    McCrae, Keith
    Khorana, Alok A.
    [J]. TARGETED ONCOLOGY, 2022, 17 (05) : 563 - 569
  • [29] The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
    Sakata, Yoshihiko
    Kawamura, Kodai
    Ichikado, Kazuya
    Shingu, Naoki
    Yasuda, Yuko
    Eguchi, Yoshitomo
    Anan, Keisuke
    Hisanaga, Junpei
    Nitawaki, Tatsuya
    Iio, Miwa
    Sekido, Yuko
    Nakan, Aiko
    Sakagami, Takuro
    [J]. LUNG CANCER, 2019, 130 : 159 - 161
  • [30] Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer Reply
    Passaro, Antonio
    Spitaleri, Gianluca
    de Marinis, Filippo
    [J]. CLINICAL LUNG CANCER, 2020, 21 (05) : E415 - E416
12345